A Vaccine of SARS-CoV-2 S Protein RBD Induces Protective Immunity

文献类型： 外文期刊

第一作者： Qu, Qiaoqiao

作者： Qu, Qiaoqiao;Qu, Qiaoqiao;Hao, Pengfei;Xu, Wang;Li, Letian;Jiang, Yuhang;Xu, Zhiqiang;Chen, Jing;Gao, Zihan;Pang, Zhaoxia;Jin, Ningyi;Li, Chang

作者机构：

关键词： severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2); coronavirus disease 2019 (COVID-19); the receptor binding domain (RBD); the six-helix bundle (6HB)

期刊名称：INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES （ 影响因子：6.208； 五年影响因子：6.628 ）

ISSN：

年卷期： 2022 年 23 卷 22 期

页码：

收录情况： SCI

摘要： The pandemic of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has posed great threat to the world in many aspects. There is an urgent requirement for an effective preventive vaccine. The receptor binding domain (RBD), located on the spike (S) gene, is responsible for binding to the angiotensin-converting enzyme 2 (ACE2) receptor of host cells. The RBD protein is an effective and safe antigen candidate. The six-helix bundle (6HB) "molecular clamp" is a novel thermally-stable trimerization domain derived from a human immunodeficiency virus (HIV) gp41 protein segment. We selected the baculovirus system to fuse and express the RBD protein and 6HB for imitating the natural trimeric structure of RBD, named RBD-6HB. Recombinant RBD-6HB was successfully obtained from the cell culture supernatant and purified to high homogeneity. The purity of the final protein preparation was more than 97%. The results showed that the protein was identified as a homogeneous polymer. Further studies showed that the RBD-6HB protein combined with AL/CpG adjuvant could stimulate animals to produce sustained high-level antibodies and establish an effective protective barrier to protect mice from challenges. Our findings highlight the importance of trimerized SARS-CoV-2 S protein RBD in designing SARS-CoV-2 vaccines and provide a rationale for developing a protective vaccine through the induction of antibodies against the RBD domain.

分类号：

  • 相关文献
作者其他论文 更多>>

微信小程序